Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomized, Active-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

NCT02761512 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.

NCT NCT02761512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02761512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomized, Active-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
Lead sponsor
HK inno.N Corporation
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2016
Completion date
December 28, 2018
Enrollment
306 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric ulcer